Allergic Asthma Therapeutics Market Size, Trends, Shares, Insights 2027

In June 2017, Teva Pharmaceuticals Industries Ltd. received the U.S. FDA approval for its three products; ArmonAir, RespiClick, and AirDuo RespiClick. These are asthma inhalers for adult as well as adolescent patients suffering from asthma.


Commenting only available for logged in users